AllianceBernstein’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $21K | Hold |
|
|||||
|
2024
Q4 | $23.4K | Hold |
|
|||||
|
2024
Q3 | $42.2K | Hold |
|
|||||
|
2024
Q2 | $46.5K | Buy |
|
|||||
|
2024
Q1 | $26.2K | Hold |
|
|||||
|
2023
Q4 | $19.3K | Hold |
|
|||||
|
2023
Q3 | $20.9K | Buy |
|
|||||
|
2023
Q2 | $18.2K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $42K | Sell |
|
|||||
|
2021
Q4 | $83K | Hold |
|
|||||
|
2021
Q3 | $85K | Hold |
|
|||||
|
2021
Q2 | $96K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $83K | Buy |
|
|||||
|
2019
Q4 | $83K | Hold |
|
|||||
|
2019
Q3 | $91K | Sell |
|
|||||
|
2019
Q2 | $107K | Buy |
|
|||||
|
2019
Q1 | $118K | Sell |
|
|||||
|
2018
Q4 | $91K | Sell |
|
|||||
|
2018
Q3 | $234K | Buy |
|
|||||
|
2018
Q2 | $195K | Sell |
|
|||||
|
2018
Q1 | $260K | Buy |
|
|||||
|
2017
Q4 | $187K | Buy |
|
|||||
|
2017
Q3 | $238K | Hold |
|
|||||
|
2017
Q2 | $264K | Buy |
|
|||||
|
2017
Q1 | $189K | Hold |
|
|||||
|
2016
Q4 | $198K | Buy |
|
|||||
|
2016
Q3 | $205K | Hold |
|
|||||
|
2016
Q2 | $137K | Buy |
|
|||||
|
2016
Q1 | $141K | Sell |
|
|||||
|
2015
Q4 | $215K | Buy |
|
|||||
|
2015
Q3 | $148K | Hold |
|
|||||
|
2015
Q2 | $179K | Buy |
|
|||||
|
2015
Q1 | $207K | Buy |
|
|||||
|
2014
Q4 | $126K | Sell |
|
|||||
|
2014
Q3 | $108K | Sell |
|
|||||
|
2014
Q2 | $125K | Buy |
|
|||||
|
2014
Q1 | $129K | Sell |
|
|||||
|
2013
Q4 | $164K | Sell |
|
|||||
|
2013
Q3 | $185K | Sell |
|
|||||
|
2013
Q2 | $204K | Buy |
|